Partikula Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Partikula General Information


Developer of novel therapeutics designed to treat oncology and other diseases. The company's therapeutics utilize proprietary chemical engineering technologies to develop compounds that specifically and directly target mitochondria, from the outer mitochondrial membrane to the mitochondrial matrix and areas in between, enabling patients to fight off a large number of major diseases including cancer, neurodegenerative disease, cardiovascular and metabolic disease and a number of rare orphan diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Corporate Office
  • 15491 South West 12th Street
  • Suite 408
  • Sunrise, FL 33326
  • United States
+1 (954) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Partikula Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Apr-2018 00.000 Completed Out of Business
4. Debt - General 30-Jun-2016 00.000 Completed Startup
3. Debt - General 20-Nov-2015 00.000 Completed Startup
2. Early Stage VC (Series A) 02-Feb-2015 $5M $5.15M Completed Startup
1. Angel (individual) 25-Mar-2014 $150K $150K Completed Startup
To view Partikula’s complete valuation and funding history, request access »

Partikula Comparisons

HQ Location
Total Raised
Post Valuation
Developer of novel therapeutics designed to treat oncology and other diseases. The company's therapeutics utilize propri
Sunrise, FL
00000000 00 00.000


didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
Bala Cynwyd, PA
00 As of 0000
00000000 00000


ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incidid
Lund, Sweden
0 As of 0000
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Partikula Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Larimar Therapeutics Formerly VC-backed Bala Cynwyd, PA 00 00000 00000000 00000
Abliva Formerly VC-backed Lund, Sweden 0 000.00 000000000 000.00
You’re viewing 2 of 2 competitors. Get the full list »

Partikula Executive Team (4)

Name Title Board Seat Contact Info
David Kolb Chief Executive Officer, Co-Founder & Board Member
Marc Lippman MD Chief Medical Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Partikula Board Members (4)

Name Representing Role Since
David Kolb Self Chief Executive Officer, Co-Founder & Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »

Partikula FAQs

  • When was Partikula founded?

    Partikula was founded in 2013.

  • Who is the founder of Partikula?

    Shanta Dhar Ph.D and David Kolb are the founders of Partikula.

  • Who is the CEO of Partikula?

    David Kolb is the CEO of Partikula.

  • Where is Partikula headquartered?

    Partikula is headquartered in Sunrise, FL.

  • What industry is Partikula in?

    Partikula’s primary industry is Biotechnology.

  • Is Partikula a private or public company?

    Partikula is a Private company.

  • What is Partikula’s current revenue?

    The current revenue for Partikula is 00000.

  • How much funding has Partikula raised over time?

    Partikula has raised $5.15M.

  • Who are Partikula’s competitors?

    Larimar Therapeutics and Abliva are competitors of Partikula.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »